Online ISSN: 1945-4589
Editorial Volume 13, Issue 18 pp 21812—21813

SERPINA3 in glioblastoma and Alzheimer’s disease

Emily S. Norton1,2,3, , Sandro Da Mesquita4, , Hugo Guerrero-Cazares1,2,3, ,

  • 1 Department of Neurosurgery, Mayo Clinic, Jacksonville, FL 32224, USA
  • 2 Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL 32224, USA
  • 3 Regenerative Sciences Training Program, Center for Regenerative Medicine, Mayo Clinic, Jacksonville, FL 32224, USA
  • 4 Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA

Received: September 7, 2021       Published: September 29, 2021      

https://doi.org/10.18632/aging.203603
How to Cite

Copyright: © 2021 Norton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download PDF
Corresponding Author

Hugo Guerrero-Cazares
Guerrero-Cazares.Hugo@mayo.edu

Keywords
alpha-1 antichymotrypsin glioblastoma cerebrospinal fluid aging astrocyte Alzheimer’s disease SERPINA3